Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Recurrent B-cell neoplasms after Rituximab therapy: an immunophenotypic and genotypic study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Recurrent B-cell neoplasms after Rituximab therapy: an immunophenotypic and genotypic study.
Recurrent B-cell neoplasms after Rituximab therapy: an immunophenotypic and genotypic study. Leuk Lymphoma. 2002 Dec; 43(12):2335-41.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20
Antineoplastic Combined Chemotherapy Protocols
Follow-Up Studies
Gene Rearrangement, B-Lymphocyte, Heavy Chain
Gene Rearrangement, B-Lymphocyte, Light Chain
Genotype
Hematopoietic Stem Cell Transplantation
Humans
Immunophenotyping
Leukemia, B-Cell
Lymphoma, B-Cell
Recurrence
Rituximab
Treatment Failure
authors with profiles
Daniel Arber